XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Sales:        
Total sales $ 11,981 $ 14,088 $ 24,350 $ 25,476
Cost of sales:        
Total cost of sales 7,781 9,720 16,536 17,730
Gross profit 4,200 4,368 7,814 7,746
Operating expenses:        
Engineering and development 717 762 1,344 1,491
Selling, general and administrative 3,507 3,727 6,890 6,913
Total operating expenses 4,224 4,489 8,234 8,404
Operating loss (24) (121) (420) (658)
Other income (expense):        
Foreign exchange gain (loss) 176 (154) 159 (621)
Interest expense (101) (75) (206) (113)
Interest income 126 133 271 231
Gain on forgiveness of debt       2,196
Other income (expense), net (16) 93 3 102
Total other income (expense), net 185 (3) 227 1,795
Income (loss) before income taxes 161 (124) (193) 1,137
Income tax expense 5 723 17 833
Net income (loss) 156 (847) (210) 304
Net income (loss) attributable to common shareholders $ 148 $ (847) $ (210) $ 289
Net income (loss) per share - basic $ 0.03 $ (0.20) $ (0.05) $ 0.07
Weighted average shares outstanding - basic 4,274 4,158 4,237 4,117
Net income (loss) per share - diluted $ 0.03 $ (0.20) $ (0.05) $ 0.07
Weighted average shares outstanding - diluted 4,285 4,158 4,237 4,202
Product        
Sales:        
Total sales $ 8,217 $ 10,976 $ 16,937 $ 19,384
Cost of sales:        
Total cost of sales 6,265 8,553 13,542 15,502
Services        
Sales:        
Total sales 3,764 3,112 7,413 6,092
Cost of sales:        
Total cost of sales $ 1,516 $ 1,167 $ 2,994 $ 2,228